Ms Margaret Gallagher, in New Hyde Park, NY - Pharmacist

Ms Margaret Gallagher, is a Pharmacist based in New Hyde Park, New York. Ms Margaret Gallagher is licensed to practice in New York (license number 37752) and her current practice location is 310 Hillside Ave, New Hyde Park, New York. She can be reached at her office (for appointments etc.) via phone at (516) 326-3506.

NPI number for Ms Margaret Gallagher is 1083936603 and her current mailing address is 310 Hillside Ave, New Hyde Park, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1083936603.

Contact Information

	Ms Margaret Gallagher,
	310 Hillside Ave, New Hyde Park, NY 11040-2525
	(516) 326-3506
	(516) 326-3512

Healthcare Provider's Profile

Full Name	Ms Margaret Gallagher
Gender	Female
Speciality	Pharmacist
Location	310 Hillside Ave, New Hyde Park, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1083936603
Provider Enumeration Date: 02/23/2010
Last Update Date: 02/23/2010

Medical Identifiers

Medical identifiers for Ms Margaret Gallagher such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083936603	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	37752 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Margaret Gallagher is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Margaret Gallagher, 310 Hillside Ave, New Hyde Park, NY 11040-2525 Ph: (516) 326-3506	Ms Margaret Gallagher, 310 Hillside Ave, New Hyde Park, NY 11040-2525 Ph: (516) 326-3506

News Archive

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

Laser-induced breakdown spectroscopy emerges as fast, cost-efficient method for biomass analysis

Laser-induced breakdown spectroscopy (LIBS) is emerging as a fast, cost-efficient method for identifying the total amount and specific compounds that comprise the inorganic component of biomass. Accurate and reliable analysis of these minerals, such as aluminum, calcium, iron, and silicon is essential, as this "ash" can cause problems when converting biomass to hydrocarbon biofuels, as described in a study published in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Probiodrug AG, collaborators explain interplay of key suspects in Alzheimer's

Probiodrug AG (Probiodrug), a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases with a particular focus on Alzheimer's disease (AD), today announced its scientists and academics collaborators published seminal findings on the role of pyroglu Aβ in AD pathology in the May 2, 2012 online edition of the journal Nature (DOI: 10.1038/nature11060). The new findings add to the growing body of evidence that pyroglu Aβ plays a crucial role in the initiation of AD. In addition, the research results further elucidate the mechanism by which pyroglu Aβ triggers neuronal toxicity.

Thrombogenics announces publication of positive microplasmin Phase II trial results

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.

MDI Biological Laboratory announces expansion of innovative data literacy program

The MDI Biological Laboratory has announced that it is expanding its innovative SEPA (Science Education Partnership Award) program, which aims to improve secondary school education in data literacy while addressing the public health threat posed by arsenic in well water.

Pharmacist in New Hyde Park, NY

Morton Shaw, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1983 Marcus Ave, Suite C-100, New Hyde Park, NY 11042 Phone: 516-352-8548 Fax: 516-352-8564
Dr. Mohammad Alam, PHARMD, MBA, BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26901 76th Ave, New Hyde Park, NY 11040 Phone: 516-724-2809
Kiet Mai, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 911 Hillside Avenue, New Hyde Park, NY 11040 Phone: 516-710-1134
Shiney Abraham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 270-05 76th Avenue, New Hyde Park, NY 11040 Phone: 718-470-7400
Dr. Milan Sharma, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7604 268th St, New Hyde Park, NY 11040 Phone: 516-343-7454
Ms. Maribeth Anne Lavin, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27111 76th Ave, New Hyde Park, NY 11040 Phone: 718-289-2272 Fax: 718-289-2274
Jane L Esposito, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 657 Hillside Ave, New Hyde Park, NY 11040 Phone: 516-328-3434

Ms Margaret Gallagher, - Pharmacist in New Hyde Park, NY